Matches in Nanopublications for { <http://bio2rdf.org/drugbank_resource:DB00361_DB00701> ?p ?o ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- drugbank_resource:DB00361_DB00701 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00361_DB00701 label "DDI between Vinorelbine and Amprenavir - Amprenavir, a strong CYP3A4 inhibitor, may increase the serum concentration of Vinorelbine by decreasing its metabolism. Consider alternate therapy to avoid Vinorelbine toxicity. Monitor for changes in the therapeutic and adverse effects of Vinorelbine if Amprenavir is initiated, discontinued or dose changed. [drugbank_resource:DB00361_DB00701]" assertion.
- drugbank_resource:DB00361_DB00701 identifier "drugbank_resource:DB00361_DB00701" assertion.
- drugbank_resource:DB00361_DB00701 title "DDI between Vinorelbine and Amprenavir - Amprenavir, a strong CYP3A4 inhibitor, may increase the serum concentration of Vinorelbine by decreasing its metabolism. Consider alternate therapy to avoid Vinorelbine toxicity. Monitor for changes in the therapeutic and adverse effects of Vinorelbine if Amprenavir is initiated, discontinued or dose changed." assertion.